Corrigendum to 'Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins' [Redox Biol. 41 (2021) 101905]

Affiliations

• ¹ Department of Oncology, University of Alberta, Edmonton, AB, T6G2R3, Canada.
• ² Department of Oncology, University of Alberta, Edmonton, AB, T6G2R3, Canada; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria, El Sultan Hussein St. Azarita, Alexandria, Egypt.
• ³ Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, AB, T6G2R3, Canada.
• ⁴ Alberta Proteomics and Mass Spectrometry Facility, University of Alberta, Edmonton, AB, T6G2R3, Canada.
• ⁵ Department of Chemical & Materials Engineering, University of Alberta, Edmonton, AB, T6G2R3, Canada.
• ⁶ Radiation Oncology, School of Medicine, Duke University, Durham, NC, 27708, United States.
• ⁷ Department of Biochemistry, University of Alberta, Edmonton, AB, T6G2R3, Canada.
• ⁸ Department of Oncology, University of Alberta, Edmonton, AB, T6G2R3, Canada. Electronic address: mweinfel@ualberta.ca.